Core Insights - JD Overseas Medical is accelerating its global strategy since 2025, forming strategic partnerships with top medical institutions in the U.S. to enhance its "Direct Link and Delivery" service model [1][5][6] Group 1: Strategic Partnerships - JD Overseas Medical has signed agreements with renowned institutions such as Northwestern Memorial Hospital and USC Keck Medicine to deepen its service offerings in complex disease treatment [1][5] - The collaboration with Northwestern Memorial Hospital focuses on complex disease diagnosis and treatment, leveraging its expertise in areas like neurosurgery and transplant medicine [5] - The partnership with USC Keck Medicine aims to provide advanced cancer treatment and organ transplant services, enhancing remote consultation capabilities for Chinese patients [6] Group 2: Service Model and Patient Experience - The "Direct Link and Delivery" model aims to streamline the overseas medical process, addressing pain points in institution selection, process management, and cross-border communication [1][7] - JD Overseas Medical offers a comprehensive service cycle, including pre-departure consultation and post-return health management, improving referral efficiency and reducing intermediaries [7] - The platform integrates health management resources from both domestic and international partners, providing a seamless healthcare experience for patients [7] Group 3: Global Resource Integration - JD Overseas Medical has gathered top medical resources from over 10 countries, including Switzerland, Japan, and the U.S., covering various specialties such as reproductive assistance and chronic disease management [7] - The service includes access to information on over 100 top hospitals and doctors globally, enhancing the quality of care available to patients [7] Group 4: Future Plans - JD Overseas Medical plans to collaborate with more global partners to provide comprehensive medical support, aiming to offer world-class healthcare services to a broader patient base [7] - Users can access the overseas medical services through the JD APP, ensuring a professional and convenient cross-border healthcare experience [7]

Core Insights - JD Overseas Medical is deepening its global resource layout by forming strategic partnerships with leading medical institutions in Hong Kong, Japan, and Thailand to enhance its one-stop service model for cross-border medical care [1][3][5] Group 1: Strategic Partnerships - In 2025, JD Overseas Medical partnered with Hong Kong's Pao De Medical Group, Japan's Medical Corporation Keikokai, and Thailand's Khaomun International Hospital to advance its "Direct Link and Delivery" service model [1][3][5] - The collaboration with Medical Corporation Keikokai focuses on high-end health check-ups and specialized treatments, leveraging its expertise in early cancer diagnosis and ultrasound therapy [1] - The partnership with Pao De Medical Group aims to provide advanced reproductive health services, including IVF and fertility preservation, addressing challenges in medical institution selection and appointment processes for Chinese families [3] Group 2: Service Offerings - JD Overseas Medical's platform includes a comprehensive database of over 100 top global hospitals and doctors, providing users with access to the latest approved drugs and cutting-edge therapies [7] - The platform facilitates a full-service process from consultation to return management, reducing intermediary costs and improving resource matching efficiency [7] - The collaboration with Khaomun International Hospital aims to create an integrated medical tourism experience, combining treatment, rehabilitation, and lifestyle services for international patients [5] Group 3: Future Directions - JD Overseas Medical plans to continue expanding partnerships with high-quality international medical institutions to strengthen its integrated health management services [11] - The company aims to transition from merely treating illnesses to providing comprehensive health management solutions, enhancing user experience in cross-border medical choices [11]